08:30-08:50 | Keynote |
Epitope Specificity of Pre-existing Human Anti-PEG Antibodies and Immune Evasion via Hydroxy-Terminated PEGylation |
|
||||
08:50-09:10 | Keynote |
|
|
||||
09:10-09:25 | Invited |
The fundamental mechanism of the cellular uptake of nanoparticles of different sizes |
|
||||
09:25-09:40 | Invited |
|
|
||||
09:40-09:55 | Invited |
|
|
||||
09:55-10:10 | Invited |
|
|
||||
10:10-10:20 | Oral Report |
A study of the pharmacokinetics of self-assembled peptide nanomaterials in healthy mice based on ICP-MS |
|
||||
10:20-10:30 | Other |
Coffee Break |
10:30-10:50 | Keynote |
Enhanced Renal Health: Investigating Nanomaterial Metabolism and Therapeutic Applications in Kidney Care |
|
||||
10:50-11:10 | Keynote |
|
|
||||
11:10-11:25 | Invited |
Ex vivo biosensor model reveals the extrapulmonary effect and toxicological mechanism of inhaled fine particulate matters |
|
||||
11:25-11:40 | Invited |
Adverse effects and mechanisms of silica nanoparticles-induced respiratory system injury |
|
||||
11:40-11:55 | Invited |
Size-mixing effect of titanium dioxide on the occurrence and progression of colitis-associated colorectal cancer |
|
||||
11:55-13:30 | Other |
Lunch |